PERSPECTA

News from every angle

← Back to headlines

Intensity Therapeutics Targets INVINCIBLE-4 Enrollment by 2027, Seeks $30M for INVINCIBLE-3

Intensity Therapeutics aims to complete enrollment for its INVINCIBLE-4 clinical trial by the end of 2027, while also seeking $30 million in funding to finalize its INVINCIBLE-3 trial.

11 Aug, 17:48 — 11 Aug, 17:48
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed6d ago

Intensity therapeutics targets INVINCIBLE-4 enrollment completion by end of 2027 while seeking $30M to finish INVINCIBLE-3

Read full article →

Related Stories

Bulgaria Returns 11.6 Tons of Peppers to North Macedonia Due to Pesticides

35m ago

Goldman Sachs to Acquire ETF Provider Neos in $2.3 Billion Deal

41m ago

L3Harris CEO Chris Kubasik Ousted Over Unspecified Conduct

42m ago

KBR Secures $60 Million NATO Contract for Missile Defense System

52m ago